1. Home
  2. BLUW vs GALT Comparison

BLUW vs GALT Comparison

Compare BLUW & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLUW

Blue Water Acquisition Corp. III Class A Ordinary Shares

HOLD

Current Price

$10.35

Market Cap

334.1M

Sector

N/A

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.02

Market Cap

297.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLUW
GALT
Founded
2024
2000
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.1M
297.0M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BLUW
GALT
Price
$10.35
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
27.9K
524.5K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
36.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.94
$2.03
52 Week High
$10.41
$7.13

Technical Indicators

Market Signals
Indicator
BLUW
GALT
Relative Strength Index (RSI) 59.37 39.70
Support Level $10.24 $2.75
Resistance Level $10.36 $3.35
Average True Range (ATR) 0.01 0.38
MACD 0.00 -0.17
Stochastic Oscillator 66.67 5.01

Price Performance

Historical Comparison
BLUW
GALT

About BLUW Blue Water Acquisition Corp. III Class A Ordinary Shares

Blue Water Acquisition Corp III is a blank check company.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: